Sign In
Buy TNON
$0.630
+0.0046 (+0.736%)
At Close: Jun 03, 2026
Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing
08:00am, Friday, 14'th Nov 2025
LOS GATOS, CA / ACCESS Newswire / November 14, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorde
Tenon Medical, Inc. (TNON) Q3 2025 Earnings Call Transcript
06:51pm, Thursday, 13'th Nov 2025
Tenon Medical, Inc. ( TNON ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Steven Foster - CEO, President & Director Kevin Williamson - Chief Financial Officer Conference Ca
Tenon(R) Medical Reports Third Quarter 2025 Financial Results
04:05pm, Thursday, 13'th Nov 2025
~ Record revenue of $1.2 million, a 32% year-over-year increase, reflecting record volume in Catamaran® SI Joint Fusion System procedures and the addition of SImmetry® SI Joint Fusion Product Sales
Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing
08:00am, Tuesday, 11'th Nov 2025
~ Strategically Placed PIPE With Industry Supportive Investor Cohort ~ LOS GATOS, CA / ACCESS Newswire / November 11, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company tra
Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results
08:30am, Monday, 03'rd Nov 2025
LOS GATOS, CA / ACCESS Newswire / November 3, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorder
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
08:30am, Tuesday, 21'st Oct 2025
~Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical approaches~ ~SImmetry+'s New 3
~ Clinically Significant Patient Outcomes Demonstrate Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at 12-Month Analysis ~ ~ 83% of Patients
Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System
08:30am, Tuesday, 19'th Aug 2025
~Full Commercial Launch with Expanded Number of Instrument Sets and Field Support to Meet Growing Market Demand ~ ~ New SI Joint Fixation Device Offers a Reduced Profile in Implant Size Providing Phys
Tenon Medical, Inc. (TNON) Q2 2025 Earnings Call Transcript
08:10pm, Wednesday, 13'th Aug 2025
Tenon Medical, Inc. (NASDAQ:TNON ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Kevin Williamson - Chief Financial Officer Steven M. Foster - CEO, President & Direc
Tenon Medical (TNON) Q2 2025 Earnings Transcript
05:12pm, Wednesday, 13'th Aug 2025
Image source: The Motley Fool.
Tenon Medical Reports Second Quarter 2025 Financial Results
04:05pm, Wednesday, 13'th Aug 2025
~ Recently Announced Strategic Acquisition of SiVantage Portfolio Energizes Tenon's Commercial Organization and Accelerates Topline Growth ~ ~ FDA Clearance Unlocks New Sacro-Pelvic Market Opportunity
Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
04:05pm, Tuesday, 05'th Aug 2025
LOS GATOS, CA / ACCESS Newswire / August 5, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ)
Tenon Medical(R) Expands Sacro-Pelvic Fusion Portfolio with Strategic Asset Acquisition
08:30am, Friday, 01'st Aug 2025
~ SiVantage Portfolio Acquisition Enhances Tenon's Sacroiliac Joint Fusion Capabilities with a Unique Multi-Product, Multi-Approach Solution ~ ~ Significant Enhancement of Tenon Medical's Commercial L
~ Andrew J. Trontis, MD from Progressive Spine and Orthopaedics, (Englewood, NJ) Completes Initial Case Series ~ LOS GATOS, CA / ACCESS Newswire / June 12, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("T
Tenon Medical, Inc. (TNON) Q1 2025 Earnings Call Transcript
09:50pm, Tuesday, 13'th May 2025
Tenon Medical, Inc. (NASDAQ:TNON ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Steve Foster - President & Chief Executive Officer Kevin Williamson - Chief Financial O
